Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288 % -61.4%
Debt-to-equity 40.6 % +153%
Return On Equity -342 % -127%
Return On Assets -243 % -87%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.3M shares +1446%
Common Stock, Shares, Outstanding 40.3M shares +1304%
Entity Public Float 5.8M USD -43.1%
Common Stock, Value, Issued 4.03K USD +1304%
Weighted Average Number of Shares Outstanding, Basic 15.6M shares +422%
Weighted Average Number of Shares Outstanding, Diluted 15.6M shares +422%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
General and Administrative Expense 4.92M USD +3.07%
Operating Income (Loss) -13M USD -23.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.01M USD -15.2%
Net Income (Loss) Attributable to Parent -12.9M USD -26%
Earnings Per Share, Basic -2 USD/shares +55.2%
Earnings Per Share, Diluted -2 USD/shares +55.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.94M USD +24.5%
Assets, Current 7.15M USD -4.34%
Property, Plant and Equipment, Net 5.02K USD +96.4%
Operating Lease, Right-of-Use Asset 24.3K USD
Other Assets, Noncurrent 173K USD -97.8%
Assets 8.18M USD +7.64%
Accounts Payable, Current 786K USD -17.6%
Accrued Liabilities, Current 1.26M USD +150%
Liabilities, Current 2.07M USD +33.7%
Operating Lease, Liability, Noncurrent 21.8K USD -80%
Liabilities 2.07M USD +31.5%
Retained Earnings (Accumulated Deficit) -94M USD -15.9%
Stockholders' Equity Attributable to Parent 6.11M USD +1.39%
Liabilities and Equity 8.18M USD +7.64%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.73M USD -33.2%
Net Cash Provided by (Used in) Financing Activities 4.44M USD -29.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 40.3M shares +1302%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.71M USD -59.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.88K USD
Deferred Tax Assets, Valuation Allowance 19.9M USD +12.8%
Deferred Tax Assets, Gross 19.9M USD +12.8%
Operating Lease, Liability 21.8K USD -80%
Depreciation 301 USD +117%
Lessee, Operating Lease, Liability, to be Paid 23.3K USD -79.8%
Operating Lease, Liability, Current 21.8K USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 70K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 70K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.52K USD -76.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 203K USD +33.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares